Bove P G, Long G W, Zelenock G B, Bendick P J, Khoury M D, Burr M O, Bechtel G, Becker F, Huckabone C
Department of Surgery, William Beaumont Hospital, Royal OAk, MI 48073, USA.
J Vasc Surg. 2000 Oct;32(4):697-703. doi: 10.1067/mva.2000.110051.
We evaluated our early experience with the transrenal fixation of aortic stent-grafts to determine the efficacy of this procedure and its effects on renal artery patency and hemodynamics.
Twenty-eight patients (22 men) had endoluminally placed modular bifurcated stent-grafts with a bare spring structure at the proximal end crossing the origin of both renal arteries; no patient with infrarenal fixation was included for analysis. The mean age of the patients was 75 +/- 7 years (range, 58-86 years); the mean aneurysm size was 5.8 +/- 0.8 cm (range, 4.7-7.2 cm). Eight patients had preoperative or intraoperative angiographic evidence of renal artery atherosclerotic disease, but only four vessels had luminal narrowing of 50% or greater. No complications were noted during stent-graft placement, and all patients have returned for follow-up visits, ranging from 1 to 12 months (mean follow-up, 6 +/- 4 months). Follow-up evaluations included clinical assessment, duplex ultrasound scan of the renal arteries and kidneys, and computed tomographic angiography.
No evidence of lobular or sublobular perfusion defects of the renal parenchyma was detected postoperatively. Two patients exhibited postoperative changes in renal artery hemodynamics-one progressing from a 30% diameter reduction to a greater than 60% diameter stenosis at the 12-month follow-up visit and one with a normal renal artery preoperatively having elevated flow velocities indicative of a greater than 60% stenosis at the 1-month visit. Of 19 patients with normal preoperative renal function, only one has had persistently elevated serum creatinine levels.
We conclude from this experience that the transrenal placement of open stents is safe and effectively excludes the aneurysm, potentially expanding the availability of this technique to more patients with a short infrarenal aortic neck. Long-term follow-up is essential to determine the overall efficacy of this technique and to identify potential effects on renal artery hemodynamics or kidney function.
我们评估了经肾固定主动脉覆膜支架移植物的早期经验,以确定该手术的疗效及其对肾动脉通畅性和血流动力学的影响。
28例患者(22例男性)接受了腔内植入的模块化分叉覆膜支架移植物,其近端为裸弹簧结构,跨过双侧肾动脉起始部;未纳入肾下固定的患者进行分析。患者的平均年龄为75±7岁(范围58 - 86岁);平均动脉瘤大小为5.8±0.8 cm(范围4.7 - 7.2 cm)。8例患者术前或术中血管造影有肾动脉粥样硬化疾病证据,但只有4支血管管腔狭窄达50%或更严重。覆膜支架植入过程中未发现并发症,所有患者均已返回进行随访,随访时间为1至12个月(平均随访6±4个月)。随访评估包括临床评估、肾动脉和肾脏的双功超声扫描以及计算机断层血管造影。
术后未发现肾实质小叶或亚小叶灌注缺损的证据。2例患者出现肾动脉血流动力学术后改变——1例在12个月随访时直径缩小从30%进展至大于60%狭窄,另1例术前肾动脉正常,在1个月随访时血流速度升高,提示大于60%狭窄。19例术前肾功能正常的患者中,只有1例血清肌酐水平持续升高。
我们从该经验得出结论,开放支架经肾植入是安全的,能有效排除动脉瘤,可能使该技术可用于更多肾下主动脉颈短的患者。长期随访对于确定该技术的总体疗效以及识别对肾动脉血流动力学或肾功能的潜在影响至关重要。